Orphan Drugs

As a result, orphan drugs aimed at dealing with the atmosphere are rare and hesitant to develop them under normal marketing conditions. The process from discovering a new patch to marketing it is a long (10x on average), precious (several million euros) and truly uncertain. Developing a drug to treat a rare condition does not pay off. Orphan drugs are defined as drugs that are not developed by for-profit pharmaceutical technology but that meet the health needs of society. Indeed, drug proposals can also be considered orphaned because one substance may be used to treat a common condition but may not have been developed for another even rarer proposition. Orphan drugs are drugs used to comment, handcuff or treat serious or genuinely voluntary or rare diseases.


    Orphan Drugs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in